News | February 06, 2024
Sun Pharma Advanced Research Company Q3 FY24 loss at Rs. 99.65 Cr
Sun Pharma Advanced Research Company has reported total income of Rs. 20.25 crores during the period ended December 31, 2023
Sun Pharma Advanced Research Company has reported total income of Rs. 20.25 crores during the period ended December 31, 2023
Sun Pharma Advanced Research Company Limited has reported total income of Rs. 29.67 crores during the period ended September 30, 2023
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021
At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.
The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.
The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020
The company will review FDA's response and decide on appropriate next steps soon.
The company posted net loss of Rs. 55.51 crores for the period ended December 31, 2019.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)